Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Virus or component thereof
Reexamination Certificate
2005-02-08
2010-02-16
Chen, Stacy B (Department: 1648)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Virus or component thereof
C424S199100
Reexamination Certificate
active
07662397
ABSTRACT:
Recombinant respiratory syncytial virus (RSV) having the position of genes shifted within the genome or antigenome of the recombinant virus are infectious and attenuated in humans and other mammals. Gene shifted RSV are constructed by insertion, deletion or rearrangement of genes or genome segments within the recombinant genome or antigenome and are useful in vaccine formulations for eliciting an anti-RSV immune response. Also provided are isolated polynucleotide molecules and vectors incorporating a recombinant RSV genome or antigenome wherein a gene or gene segment is shifted to a more promoter-proximal or promoter-distal position within the genome or antigenome compared to a wild type position of the gene in the RSV gene map. Shifting the position of genes in this manner provides for a selected increase or decrease in expression of the gene, depending on the nature and degree of the positional shift.
REFERENCES:
patent: 4683195 (1987-07-01), Mullis
patent: 4683202 (1987-07-01), Mullis
patent: 4800078 (1989-01-01), Prince
patent: 4800478 (1989-01-01), Takahashi
patent: 5922326 (1999-07-01), Murphy
patent: 5993824 (1999-11-01), Murphy
patent: 6264957 (2001-07-01), Collins
patent: 6689367 (2004-02-01), Collins
patent: 6699476 (2004-03-01), Collins
patent: 6713066 (2004-03-01), Collins
patent: 6923971 (2005-08-01), Krempl et al.
patent: WO 93/21310 (1993-10-01), None
patent: WO 97/06270 (1997-02-01), None
patent: WO 98/02530 (1998-01-01), None
patent: WO 00/61737 (2000-01-01), None
patent: WO 01/04271 (2001-01-01), None
patent: WO 01/04321 (2001-01-01), None
patent: WO 01/04335 (2001-01-01), None
Tang et al., J. Virology, 2001, 75(23):11328-11335.
Abraham et al., Sequential Transcription of the Genes of Vesicular Stomatits Virus, Proc. Natl. Acad. Sci. USA vol. 73 1504-1508 (1976).
Ahmadian et al., Expression of the ORF-2 Protein of the Human Respiratory Syncytial Virus M2 Gene Is Initiated By A Ribosomal Termination-Dependent Reinitiation Mechanism, EMBO J vol. 19 2681-2689 (2000).
Anderson et al., Antigenic Characterization of Respiratory Syncytial Virus Strains With Monoclonal Antibodies, Journal Infectious Diseases, vol. 151, No. 4, 626-633 (1985).
Atreya et al., The NS1 Protein of Human Respiratory Syncytial Virus Is A Potent Inhibitor of Minigenome Transcription and RNA Replication, J. Virol. vol. 72 1452-1461 (1998).
Bailly et al., A Recombinant Human Parainfluenza Virus Type 3 (PIV3) In Which the Nucleocapsid N Protein Has Been Replaced, Journal Virology, vol. 74, No. 7, 3188-3195 (2000).
Ball et al., Transcriptional Mapping of Vesicular Stomatitis Virus In Vivo, J. Virol. vol. 21 411-414 (1977)
Ball et al., Phenotypic Consequences of Rearranging the P, M, and G. Genes of Vesicular Stomatitis Virus, Journal Virology, vol. 73, No. 6, 4705-4712 (1999).
Ball et al., Order of Transcription of Genes of Vesicular Stomatitis Virus, Proc. Natl. Acad. Sci. USA vol. 73 442-446 (1976).
Banerjee et al., Vesicular Stomatitis Virus: Mode of Transcription, J. Gen. Virol. vol. 34 1-8 (1977).
Banerjee et al., Gene Expression of Nonsegmented Negative Strand RNA Viruses, Pharmacol. Ther. vol. 51 47-70 (1991).
Baron et al., Rescue of Rinderpest Virus From Cloned cDNA, Journal Virology, vol. 71, No. 2, 1265-1271 (1997).
Barr et al., Sequence of the Phosphoprotein Gene of Pneumonia Virus of Mice; Expression of Multiple Proteins from Two Overlapping Reading Frames, J. Virol. vol. 68 5330-5334 (1994).
Barr et al., Role of the Intergenic Dinucleotide in Vesicular Stomatitis Virus RNA Transcription, J. Virol. vol. 71 1794-1801 (1997).
Belshe et al., Evaluation of Five Temperature-Sensitive Mutants of Respiratory Syncytial virus In Primates, Journal Medical Virology, vol. 3, 101-110 (1978).
Belshe et al., Experimental Respiratory Syncytial Virus Infection of Four Species of Primates, Journal Medical Virology, vol. 1, 157-162 (1977).
Bermingham et al., The M2-2 Protein of Human Respiratory Syncytial Virus, Proc. Natl. Acad. Sci., vol. 96 11259-11264 (1999).
Buchholz et al., Chimeric Bovine Respiratory Syncytial Virus With Glycoprotein Gene Substitutions, Journal Virology, vol. 74, No. 3, 1187-1199 (2000).
Buccholz et al., Generation of Bovine Respiratory Syncytial Virus (BRSV) from cDNA, Journal Virology, vol. 73, No. 1, 251-259 (1999).
Bukreyev et al., Interferon Gamma Expressed By A Recombinant Respiratory Syncytial Virus, Proc. Natl. Acad. Sci., vol. 96 2367-2372 (1999).
Bukreyev et al., Recombinant Respiratory Syncytial Virus From Which Entire SH Gene Deleted Grows In Cell Culture, Journal Virology, vol. 71, No. 12, 8973-8982 (1997).
Bukreyev et al., Recovery of Infectious Respiratory Syncytial Virus Expressing An Additional, Foreign Gene, Journal Virology, vol. 70, No. 10, 6634-6641 (1996).
Byrappa et al., A Highly efficient Procedure for Site Specific Mutagenesis of Full-length Plasmids Using Vent DNA Polymerase, Genome Research vol. 5 404-407 (1995).
Cahour et al., Growth Restricted Dengue Virus Mutants Containing Deletions In the 5′ Noncoding Region of the RNA Genome, Virology vol. 207 68-76 (1995).
Chanock et al., Viral Infections of Humans, 3rd ed., A.S. Evans, Ed., Plenum Press, N.Y. (1989).
Cheng et al., Effective Amplification of Long Targets From Cloned Inserts and Human Genomic DNA, Proc. Natl. Acad. Sci. USA, vol. 91, 5695-5699 (1994).
Chin et al., Field Evaluation of A respiratory Syncytial Virus Vaccine and A Trivalent Parainfluenza Virus Vaccine In A Pediatric Population, Am. J. Epidemiol. vol. 89 449-463 (1969).
Clements et al., Evaluation of Bovine Cold-Adapted Human, and Wild-Type Human Parainfluenza Type 3 Viruses in Adult Volunteers, J. Clinical Microbiology, vol. 29, 1175-1182 (1991).
Collins et al., Rational Design of Live Attenuated Recombinant Vaccine Virus For Human Respiratory Syncytial Virus by Reverse Genetics, Adv. Virus Res. vol. 54 423-451 (1999).
Collins et al., Envelope-Associated 22K Protein of Human Respiratory Syncytial Virus, Journal Virology, vol. 54, No. 1, 65-71 (1985).
Collins et al., Identification of a Tenth mRNA of Respiratory Syncytial Virus and Assignment of Polypeptides to the 10 Viral Genes, J. Virol. vol. 49 572-578 (1984).
Collins et al., cDNA Cloning and Transcription Mapping of Nine Polyadenylylated RNAs Encoded by the Genome of Human Respiratory Syncytial Virus, Proc. Natl. Acad. Sci. USA vol. 80 3208-3212 (1983).
Collins et al., Nucleotide sequences for the Gene Junctions of Human Respiratory Syncytial Virus Reveal Distinctive Features of Intergenic Structure and Gene Order, Proc. Natl. Acad. Sci. USA vol. 83 4594-4598 (1986).
Collins et al., Gene Overlap and Site Specific Attenuation of Transcription of the Viral Polymerase L Gene of Human Respiratory Syncytial Virus, Proc. Natl. Acad. Sci. USA vol. 84 5134-5138 (1987).
Collins et al., Transcription Elongation Factor of Respiratory Syncytial Virus, A Nonsegmented Negative Strand RNA Virus, Proc. Natl. Acad. Sci. USA vol. 93 81-85 (1996).
Collins et al., Production of Infectious Human Respiratory Syncytial Virus From Cloned cDNA, Pro. Natl. Acad. Sci., vol. 92, 11563-11567 (1995).
Collins et al., Respiratory Syncytial Virus, Fields Virology, Second Ed., 1313-1352, (1996).
Collins et al., Support Plasmids and Support Proteins Required for Recovery of Recombinant Respiratory Syncytial Virus, Virology, vol. 259, 251-255 (1999).
Collins et al., Two Open Reading Frames of 22K mRNA of Human Respiratory Syncytial Virus, Journal General Virology, vol. 71, 3015-3020 (1990).
Collins et al., Evaluation In Chimpanzees of Vaccinia Virus Recombinants that Express The Surface Glycoproteins of Human Respiratory Syncytial Virus, Vaccine vol. 8 164-168 (1990).
Collins et al., Rescue of Synthetic Analogs of Respiratory Syncytial Virus Genomic RNA, Proc. Natl. Acad. Sci., vol. 88 9663-9667 (1991).
Connors et al., A Cold Passaged Attenuated Strain of Human Respiratory Syncytial Virus Contains Mutations in the F and L Genes, Virology, vol. 208, 478-484 (1995).
Connors et al., Respiratory Syncytial Virus (RSV) F, G, M2 (22K), and N Proteins each induce Resistance to RSV Challenge, But Resistance Induced b
Buchholz Ursula
Collins Peter L.
Krempl Christine D.
Murphy Brian R.
Whitehead Stephen S.
Chen Stacy B
The United States of America as represented by the Department of
Woodcock & Washburn LLP
LandOfFree
Respiratory syncytial virus vaccines expressing protective... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Respiratory syncytial virus vaccines expressing protective..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Respiratory syncytial virus vaccines expressing protective... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4204951